Sequencing Identifies Relapse-Prone AML Patients.

Abstract excerpt

For patients with acute myeloid leukemia, DNA sequencing before stem cell transplant can predict the chances of relapse, research shows. Scientists found that NPM1 alterations and/or FLT3 internal tandem duplications that persist after treatment and prior to a stem cell transplant were better predictors of relapse than flow cytometry.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to fms-Like Tyrosine Kinase 3
• Share to Leukemia, Myeloid, Acute
• Share to Mutation